GBA-PARK: GBA1 mutations in Parkinson disease: clinical and biochemical prodrome, risk profile and pathogenetic modelling for therapeutic intervention

GBA-PARK: GBA1 mutations in Parkinson disease: clinical and biochemical prodrome, risk profile and pathogenetic modelling for therapeutic intervention

Investments > €500k|JPND Projects
Canada|Germany|Italy|JPND|United Kingdom
Parkinson’s disease & PD-related disorders
2016

 

 

Post
Filter